- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID USOR 23046_CVAY736Q12201_TPO_RA *STAR*
Trial Description
A phase 2 study to evaluate the efficacy and safety of ianalumab (VAY736) in patients with primary immune thrombocytopenia (ITP) previously treated with at least a corticosteroid and a thrombopoietin receptor agonist
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724